妊娠期糖尿病的形状 牙肌 lncRNA在怀孕早期的表达:一个前性队列研究
Alejandra Chaparro1,2, María José Bendek1,2, María Luisa Mizgier1,2
1Center for Biomedical Research and Innovation (CIIB), Universidad de Los Andes, Santiago, Chile.
Journal of periodontal research
|September 9, 2025
概括
这项研究在牙液中发现了特定的长非编码RNA (lncRNAs),这可能表明妊娠糖尿病的风险. 增加的NEAT1和LINC-PINT水平表明了早期检测的潜在生物标志物.
科学领域:
- 生物化学 生物化学
- 基因组学就是基因组学.
- 产科 产科 产科 产科 产科
背景情况:
- 孕期糖尿病 (GDM) 是一种常见的妊娠并发症.
- 早期发现GDM风险对于母亲和胎儿的健康至关重要.
- 牙裂液 (GCF) 是一种可访问的生物流体,用于生物标志物发现.
研究的目的:
- 在GCF.中识别长非编码RNA (lncRNAs) 的转录组概况.
- 探索lncRNAs作为孕妇GDM风险生物标志物的潜力.
主要方法:
- 从孕妇中采集GCF样本.
- 转录形状分析分析 lncRNA表达.
- 差异表达分析以比较GDM风险和对照组.
主要成果:
- 在GCF中识别出一个独特的lncRNA配置文件.
- 在女性中显著增加NEAT1和LINC-PINT的表达,这些女性后来发展了GDM.
- 这些lncRNAs显示出可能是GDM风险的早期指标.
结论:
- 在GCF中,NEAT1和LINC-PINT可以作为预测GDM风险的新生物标志物.
- 需要进一步的验证研究来确认它们的临床实用性.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Glucagon-like Receptor Agonists
854
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
854
Oral Hypoglycemic Agents: Biguanides and Glitazones
588
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
588
Hormones Regulating Blood Glucose
6.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.5K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K


